Loading market dashboard
Actinium Pharmaceuticals, Inc.
ATNMHealthcareAMEXUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Actinium Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $182.25M | $182.25M - $182.25M | -$109.35M | $1.655 | 3 |
| Dec 2029 | $98.17M | $98.17M - $98.17M | -$58.90M | $0.46 | 3 |
| Dec 2028 | $28.25M | $27.09M - $29.41M | -$16.95M | -$0.487 | 4 |
| Dec 2027 | $12.93M | $12.93M - $12.93M | -$7.76M | -$0.793 | 4 |
| Dec 2026 | $12.91M | $12.91M - $12.91M | -$7.75M | -$0.828 | 4 |
| Dec 2025 | $90.0K | $90.0K - $90.0K | -$54.0K | -$1.075 | 2 |
| Dec 2024 | $42.5K | $42.5K - $42.5K | -$25.5K | -$1.414 | 3 |
| Dec 2023 | $81.0K | $81.0K - $81.0K | -$16.2K | -$1.711 | 2 |
| Dec 2022 | $1.01M | $975.9K - $1.08M | -$202.4K | -$1.352 | 1 |
| Dec 2021 | $1.17M | $1.13M - $1.26M | -$234.7K | -$1.157 | 1 |